A Phase 1a/1b Open Label Dose-escalation Safety and Tolerability Study of INCB052793 in Subjects With Advanced Malignancies
-
- STATUS
- Not Recruiting
Summary
The purpose of this study is to determine the dose of INCB052793 that is safe and tolerable in subjects with advanced cancer and to select the doses that will be studied further, and to assess the safety of INCB052793 in combination with gemcitabine and nab-paclitaxel in subjects with advanced solid tumors.
Description
The purpose of this study is to determine the dose of INCB052793 that is safe and tolerable in subjects with advanced cancer and to select the doses that will be studied further, and to assess the safety of INCB052793 in combination with gemcitabine and nab-paclitaxel in subjects with advanced solid tumors.
Details
| Condition | Advanced Malignancy |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX4799 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.